Higher DHA Fatty Acids Linked To Almost 50% Reduction In Alzheimer’s Risk – Framingham Study
Researchers with 1,490 patients in multigenerational cardiovascular study found subjects with higher levels of DHA omega-3s a lower chance of developing Alzheimer’s.
You may also be interested in...
Experts in drug development, clinical care and digital therapeutics discuss gaps in the treatment landscape for Alzheimer’s disease, as well as opportunities for prevention and innovation in care delivery.
Drug development for nonalcoholic steatohepatitis (NASH), a form of liver disease, is a game of incomplete information: pipeline evolution is occurring in parallel with continued efforts to better understand and manage the disease. To date, no therapy for patients with NASH has been approved and consequences of the condition can be severe, including cirrhosis and hepatocellular carcinoma.
Moderate to severe vitamin D deficiency is associated with increased cardiovascular risk, according to results of a study of more than 1,700 offspring of participants in the Framingham Heart Study